Does Lutein Supplementation Eye Strain Randomized Trial work?

The current Migaku evidence database contains 2 reusable source documents for Lutein Supplementation Eye Strain Randomized Trial. This answer focuses on strength of evidence and what the studies can or cannot prove. - This systematic review aimed to evaluate randomized controlled trial (RCT) evidence on the effects of carotenoids, anthocyanins, polyunsaturated fatty acids, and combined nutraceutical formulations on refractive outcomes, axial length, macular pigment optical density (MPOD), visual function, and symptoms of visual fatigue. [Martinez-Perez C (2025); evidence level 1] - Eligible studies were RCTs involving individuals with myopia or at risk of myopia, comparing nutritional supplementation with placebo or active controls. [Martinez-Perez C (2025); evidence level 1] - Two reviewers independently screened studies, extracted data, and assessed risk of bias using the Cochrane RoB 2 tool. [Martinez-Perez C (2025); evidence level 1] - Background/objectives Nutritional supplementation has been proposed as a potential adjunct strategy in myopia prevention and control through antioxidative, anti-inflammatory, and extracellular matrix-regulating mechanisms. [Martinez-Perez C (2025); evidence level 1] - Many clinical trials, including the Age-Related Eye Disease Study 1 and 2 (AREDS1 and AREDS2), have suggested that supplementation with retinal carotenoids reduces the risk of retinal diseases such as age-related macular degeneration (AMD) [,,,,]. [Li Binxing (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.